Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Jordan

Showing results (11-20 of 103) with videos related to

Pageof 11
Sort By:
Bulletin of the World Health Organization|May 17, 2013
Viral suppression after 12 months of antiretroviral therapy in low- and middle-income countries: a systematic reviewJames H McMahon, Julian H Elliott, Silvia Bertagnolio, et al.
Plos One|February 21, 2013
Effects of physical tracing on estimates of loss to follow-up, mortality and retention in low and middle income country antiretroviral therapy programs: a systematic reviewJames H McMahon, Julian H Elliott, Steven Y Hong, et al.
AIDS Care|December 1, 2018
Content guidance for mobile phones short message service (SMS)-based antiretroviral therapy adherence and appointment reminders: a review of the literatureAndrew Kerrigan, Nadi N Kaonga, Alice M Tang, et al.
AIDS Reviews|September 5, 2013
Systematic review of HIV drug resistance in Southeast AsiaAndrew B Trotter, Steven Y Hong, Padmini Srikantiah, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2012
World Health Organization generic protocol to assess drug-resistant HIV among children <18 months of age and newly diagnosed with HIV in resource-limited countriesSilvia Bertagnolio, Martina Penazzato, Michael R Jordan, et al.
Infectious Disorders Drug Targets|March 17, 2011
The global status of HIV drug resistance: clinical and public-health approaches for detection, treatment and preventionSteven Y Hong, Jean B Nachega, Karen Kelley, et al.
The Lancet. Microbe|May 11, 2022
Public availability of HIV-1 drug resistance sequence and treatment data: a systematic reviewSoo-Yon Rhee, Seble G Kassaye, Michael R Jordan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2012
Evaluation of in-house genotyping assay performance using dried blood spot specimens in the Global World Health Organization laboratory networkNeil Parkin, Carmen de Mendoza, Rob Schuurman, et al.
International Journal of STD & AIDS|May 25, 2022
Determining the acceptability of point-of-care urine tenofovir testing and its performance in predicting HIV RNA suppressionTerry A Marryshow, Josephine Muhairwe, Alice Tang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2012
Prevalence of transmitted HIV drug resistance among newly diagnosed antiretroviral therapy-naive pregnant women in Lilongwe and Blantyre, MalawiNellie Wadonda-Kabondo, Richard Banda, Kundai Moyo, et al.
Pageof 11

Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
Bulletin of the World Health Organization|May 17, 2013
Viral suppression after 12 months of antiretroviral therapy in low- and middle-income countries: a systematic reviewJames H McMahon, Julian H Elliott, Silvia Bertagnolio, et al.
Plos One|February 21, 2013
Effects of physical tracing on estimates of loss to follow-up, mortality and retention in low and middle income country antiretroviral therapy programs: a systematic reviewJames H McMahon, Julian H Elliott, Steven Y Hong, et al.
AIDS Care|December 1, 2018
Content guidance for mobile phones short message service (SMS)-based antiretroviral therapy adherence and appointment reminders: a review of the literatureAndrew Kerrigan, Nadi N Kaonga, Alice M Tang, et al.
AIDS Reviews|September 5, 2013
Systematic review of HIV drug resistance in Southeast AsiaAndrew B Trotter, Steven Y Hong, Padmini Srikantiah, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2012
World Health Organization generic protocol to assess drug-resistant HIV among children <18 months of age and newly diagnosed with HIV in resource-limited countriesSilvia Bertagnolio, Martina Penazzato, Michael R Jordan, et al.
Infectious Disorders Drug Targets|March 17, 2011
The global status of HIV drug resistance: clinical and public-health approaches for detection, treatment and preventionSteven Y Hong, Jean B Nachega, Karen Kelley, et al.
The Lancet. Microbe|May 11, 2022
Public availability of HIV-1 drug resistance sequence and treatment data: a systematic reviewSoo-Yon Rhee, Seble G Kassaye, Michael R Jordan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2012
Evaluation of in-house genotyping assay performance using dried blood spot specimens in the Global World Health Organization laboratory networkNeil Parkin, Carmen de Mendoza, Rob Schuurman, et al.
International Journal of STD & AIDS|May 25, 2022
Determining the acceptability of point-of-care urine tenofovir testing and its performance in predicting HIV RNA suppressionTerry A Marryshow, Josephine Muhairwe, Alice Tang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2012
Prevalence of transmitted HIV drug resistance among newly diagnosed antiretroviral therapy-naive pregnant women in Lilongwe and Blantyre, MalawiNellie Wadonda-Kabondo, Richard Banda, Kundai Moyo, et al.
Pageof 11